Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724) (Supportive Care in Cancer, (2021), 29, 2, (833-840), 10.1007/s00520-020-05543-5)

Costantine Albany, Travis Dockter, Eric Wolfe, Jennifer Le-Rademacher, Nina Wagner-Johnston, Lawrence Einhorn, Jacqueline M. Lafky, Ellen Smith, Deirdre Pachman, Nathan Staff, Cynthia Ma, Charles L. Loprinzi, Brian A. Costello

Research output: Contribution to journalComment/debate

Abstract

After publication of the article [1], the authors identified errors in Fig. 5. Specifically, the two curves regarding paclitaxel/ CBDCA and paclitaxel were incorrect in the latter time periods. The corrected version of Fig. 5 is provided here.

Original languageEnglish
Pages (from-to)7129-7130
Number of pages2
JournalSupportive Care in Cancer
Volume29
Issue number11
DOIs
StatePublished - Nov 2021

Fingerprint

Dive into the research topics of 'Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724) (Supportive Care in Cancer, (2021), 29, 2, (833-840), 10.1007/s00520-020-05543-5)'. Together they form a unique fingerprint.

Cite this